Nelson M T, Huang Y, Brayden J E, Hescheler J, Standen N B
Department of Pharmacology, University of Vermont, Burlington 05405.
Nature. 1990 Apr 19;344(6268):770-3. doi: 10.1038/344770a0.
Calcitonin gene-related peptide (CGRP) is a 37-amino-acid peptide produced by alternative processing of messenger RNA from the calcitonin gene. CGRP is one of the most potent vasodilators known. It occurs in and is released from perivascular nerves and has been detected in the blood stream, suggesting that it is important in the control of blood flow. The mechanism by which it dilates arteries is not known. Here, we report that arterial dilations in response to CGRP are partially reversed by blockers of the ATP-sensitive potassium channel (K(ATP)), glibenclamide and barium. We also show that CGRP hyperpolarizes arterial smooth muscle and that blockers of K(ATP) channels reverse this hyperpolarization. Finally, we show that CGRP opens single K+ channels in patches on single smooth muscle cells from the same arteries. We propose that activation of K(ATP) channels underlies a substantial part of the relaxation produced by CGRP.
降钙素基因相关肽(CGRP)是一种由降钙素基因的信使核糖核酸经可变剪接产生的37个氨基酸的肽。CGRP是已知的最有效的血管舒张剂之一。它存在于血管周围神经中并从其中释放出来,并且已在血流中检测到,这表明它在控制血流方面很重要。其扩张动脉的机制尚不清楚。在这里,我们报告说,对CGRP作出反应的动脉扩张被ATP敏感性钾通道(K(ATP))阻滞剂、格列本脲和钡部分逆转。我们还表明,CGRP使动脉平滑肌超极化,并且K(ATP)通道阻滞剂可逆转这种超极化。最后,我们表明,CGRP可打开来自同一条动脉的单个平滑肌细胞上的膜片钳中的单个K+通道。我们提出,K(ATP)通道的激活是CGRP产生的大部分舒张作用的基础。